Passage Bio
PASG
PASG
45 hedge funds and large institutions have $462M invested in Passage Bio in 2020 Q1 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
45
Holders Change
+45
Holders Change %
–
% of All Funds
0.99%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.07%
New
45
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$110M |
| 2 |
FM
2
Frazier Management
Seattle,
Washington
|
$78.9M |
| 3 |
3
Fidelity Investments
Boston,
Massachusetts
|
$49.4M |
| 4 |
NLVP
4
New Leaf Venture Partners
New York
|
$39.3M |
| 5 |
VC
5
Vivo Capital
Palo Alto,
California
|
$35.1M |
Top Sellers
No sellers this quarter
